1. Home
  2. Earnings Miss
  3. Apyx Medical Reports Q1 Loss, Tops Revenue Estimates

Apyx Medical Reports Q1 Loss, Tops Revenue Estimates


Apyx Medical (NASDAQ: APYX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -22.22%. A quarter ago, it was expected that this medical device maker would post a loss of $0.13 per share when it actually produced a loss of $0.19, delivering a surprise of -46.15%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

Apyx, which belongs to the Zacks Medical – Products industry, posted revenues of $10.24 million for the quarter ended March 2024, surpassing the Zacks Consensus Estimate by 6.27%. This compares to year-ago revenues of $12.14 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

Apyx …

Full story available on Benzinga.com

Visited 1 times, 1 visit(s) today